April 27 | 2023
Notice of annual general meeting of 2cureX AB (publ)
Read more
April 25 | 2023
2cureX’s CEO Fernando Andreu purchases shares in the company
Read more
April 20 | 2023
2cureX offentliggör årsredovisning för räkenskapsåret 2022
Read more
April 20 | 2023
2cureX publishes the annual report for the fiscal year 2022
Read more
April 12 | 2023
2cureX has received a grant from the Innovation Fund Denmark to support clinical development of a novel IndiTreat® product.
Read more
April 6 | 2023
2cureX strengthens its IndiTreat® automation project with a prestigious grant from the German Federal Ministry of Education and Research
Read more
February 23 | 2023
2cureX publishes interim report for the fourth quarter and full year of 2022
Read more
February 15 | 2023
Invitation to 2cureX webcast on Year-End Report and latest news on February 24, 2023
Read more
February 10 | 2023
Announcement from extraordinary general meeting 2cureX AB
Read more
February 10 | 2023
Kommuniké från extra bolagsstämma i 2cureX AB
Read more
January 23 | 2023
KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)
Read more
January 23 | 2023
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)
Read more
January 19 | 2023
2cureX announces final results regarding 2022 goals
Read more
November 24 | 2022
2cureX publishes interim report for the third quarter and first nine months of 2022
Read more
November 14 | 2022
2cureX discloses status of 2022 plans, goals for 2023 and its estimates of potential market development in the coming years
Read more
September 29 | 2022
2cureX terminates liquidity provision service
Read more
August 25 | 2022
2cureX publishes interim report for the second quarter and first half of 2022
Read more
August 25 | 2022
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2022
Read more